Latest NICE, MHRA, NHS England and SIGN guidelines — updated automatically.
NICE NG101 covers the diagnosis and management of early and locally advanced breast cancer including surgery, radiotherapy, systemic therapy, and follow-up.
NICE NG122 covers the diagnosis, staging, and treatment of lung cancer including NSCLC and SCLC, with guidance on targeted therapy and immunotherapy.
Source: NICE View full guideline on NICE See full guideline on NICE website. ClinicalIQ Editorial Note: Sourced from NICE. Always refer to the original for clinical decisions. Verified: 25 Mar…
Source: NICE View full guideline on NICE See full guideline on NICE website. ClinicalIQ Editorial Note: Sourced from NICE. Always refer to the original for clinical decisions. Verified: 25 Mar…
Source: NICE View full guideline on NICE See full guideline on NICE website. ClinicalIQ Editorial Note: Sourced from NICE. Always refer to the original for clinical decisions. Verified: 25 Mar…
Source: NICE View full guideline on NICE See full guideline on NICE website. ClinicalIQ Editorial Note: Sourced from NICE. Always refer to the original for clinical decisions. Verified: 25 Mar…
Get weekly clinical updates — guidelines, trials, MHRA alerts — delivered to your inbox. Free for verified HCPs.
By registering you confirm you are a healthcare professional. No spam. Unsubscribe anytime.